South Dakota lawmakers on Monday approved most of the state Department of Health rules for the state’s voter-approved medical cannabis program but rejected some proposals including limiting the amount of high-potency cannabis patients can possess, requirements that medical practitioners could write recommendations for patients that want to grow more than the three plants allowed under the law, and a defined list of qualifying conditions, the Associated Press reports.
Clinical research is rapidly advancing in using psychedelic drugs to treat opioid addiction. However, psychedelics can also reduce opioid-related deaths as a SUBSTITUTE for opioids.
AdvisorShares' new psychedelics ETF commences trading today on the NYSE Arca Exchange (symbol "PSIL") with a focus on small-cap psychedelic stocks.
California activists are now cleared to begin collecting signatures for an initiative to legalize psilocybin mushrooms in the state.
House lawmakers have introduced a series of drug policy-related amendments to defense legislation, including proposals to facilitate research on the benefits of psychedelics for active duty military personnel and to protect banks that service state-legal marijuana businesses.
The legislative panel responsible for approving the rules that will govern South Dakota’s new medical marijuana law has approved a number of proposed regulations and sent other proposals back for review, in what was a crucial administrative step toward implementing the new statewide program.
Compass Pathways acquires an unspecified IP portfolio of psychedelic and emphathogenic substances.
New Hampshire lawmakers have a new strategy to legalize marijuana in the state that involves putting a proposed constitutional amendment on the ballot for voters to decide on in 2022.
Atai affiliate, Perception Neuroscience is commencing a Phase 2a clinical trial of an R-ketamine medication for the treatment of depression.
Detroit could become one of the next Michigan cities to decriminalize psychedelics, with the reform proposal making the local ballot for this November.
Cannabis flower is now available to Virginia patients who can purchase up to four ounces per month, WRIC reports.
Wesana looks to expand its TBI-based psychedelics research into MDMA, with a new research partnership with MAPS.
Big Pharma's business model for drug development is all about maximizing profits, not health. Psychedelic medicine can maximize profits AND health.
Atai Life Sciences seeks to integrate digital therapeutics into ketamine-based treatment for TRD, via its digital therapeutic platform, Introspect Digital Therapeutics.
Psychedelics media star, Hamilton Morris is joining Compass Pathways as a full-time consultant on psychedelics research.
